The regulatory status factor An important consideration that affects the risk calculus: cagrilintide is not currently FDA-approved as a standalone medication
This hormone reduces glucose production by your liver and increases its uptake by your body
Almost 5% reported a loss of appetite
This item may contain a chemical known to the State of California to cause cancer, birth defects, or other reproductive harm
Related GLP-1 Resources GLP-1 and Hair Loss: Whats Really Going On (and How to Fix It) Why Your Hair Might Be Shedding on GLP-1s (and Why Its Not Forever) Starting a GLP-1 medication is a big and exciting step toward better Surprising Ways GLP-1 Weight Loss Meds Change Your Relationship with Food If youve started GLP-1 medication even a microdose of GLP-1 through Flow Wellness you mightve noticed something strange: Youre not as hungry.Youre not craving Doctor Q&A: Common Questions About GLP-1 Medications Answered Everything You Want to Know About Medical Weight Loss If youre researching GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), youre not alone
However, due to danugliprons potential for drug-induced liver damage, 2025 Pfizer has announced that it is discontinuing development (Pfizer, 2025)
